Long-serving FDA figure Richard Pazdur has filed papers to retire, shortly after being appointed to lead the agency's Center ...

Successful AI implementation ultimately depends on how well these technologies align with the realities of clinical practice.

DTC pharma is America’s newest care pathway. TrumpRx has exposed the vacuum surrounding it.

Johnson & Johnson's Imaavy has become the first FcRn blocker to be approved in the EU as a treatment for both adolescent and ...

Bayer has started a phase 3 trial of its intrauterine contraceptive Mirena in an endometrial condition that can lead to ...

The drive to roll out AI comes after sweeping job losses at the FDA that resulted from the cost-cutting drive implemented by ...

That is the message from the latest annual report (PDF) on clinical trials from the Association of the British Pharmaceutical ...

In a new pharmaphorum podcast to kick off December - in which month we'll be bringing you an episode a day through the ...

Artificial intelligence specialist Artera has won FDA approval for AI-powered software that can help guide the management of patients diagnosed with localised prostate cancer. ArteraAI Prostate is ...

A year ago, Astellas was celebrating the first-in-class approval of its claudin 18.2-targeting cancer drug Vyloy for gastric cancers. Now, a bid to expand its label into pancreatic cancer has hit the ...

Two additional novel AI-generated targets for chronic kidney disease (CKD) and idiopathic pulmonary fibrosis (IPF) have been discovered using the Benevolent Platform and selected for AstraZeneca’s (AZ ...

Moderna has said it will open a new R&D and manufacturing facility in the UK which could lead to improved access by NHS patients to mRNA-based vaccines and drug treatments. The facility is the ...